Nanostructured mucoadhesive microparticles to enhance oral drug bioavailability.

Saved in:
Bibliographic Details
Title: Nanostructured mucoadhesive microparticles to enhance oral drug bioavailability.
Authors: Park, Chun Gwon1, Huh, Beom Kang2, Kim, Se-Na2, Lee, Seung Ho1, Hong, Hye Rim3, Choy, Young Bin1,2,3 ybchoy@snu.ac.kr
Source: Journal of Industrial & Engineering Chemistry. Oct2017, Vol. 54, p262-269. 8p.
Subjects: Nanostructured materials, Oral medication, Bioavailability, Gastrointestinal system, Losartan
Abstract: To enhance oral drug bioavailability, we propose mucoadhesive, nanostructured microparticles (PLGA/PEG NM) as a drug-delivery vehicle. The PLGA/PEG NM herein retain nanofibrous structures within microparticles, and possess a seven-fold increase in specific surface area than conventional spherical microparticles, allowing for synergistic improvement of a mucoadhesive property. In vivo evaluations demonstrated that PLGA/PEG NM showed prolonged retention in the gastrointestinal tract, as compared to control microparticles. When PLGA/PEG NM was loaded with losartan, an oral anti-hypertension drug, drug’s bioavailability increased by two-fold in comparison to a bolus losartan solution. Therefore, the PLGA/PEG NM are a promising carrier for oral drug delivery. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Industrial & Engineering Chemistry is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:To enhance oral drug bioavailability, we propose mucoadhesive, nanostructured microparticles (PLGA/PEG NM) as a drug-delivery vehicle. The PLGA/PEG NM herein retain nanofibrous structures within microparticles, and possess a seven-fold increase in specific surface area than conventional spherical microparticles, allowing for synergistic improvement of a mucoadhesive property. In vivo evaluations demonstrated that PLGA/PEG NM showed prolonged retention in the gastrointestinal tract, as compared to control microparticles. When PLGA/PEG NM was loaded with losartan, an oral anti-hypertension drug, drug’s bioavailability increased by two-fold in comparison to a bolus losartan solution. Therefore, the PLGA/PEG NM are a promising carrier for oral drug delivery. [ABSTRACT FROM AUTHOR]
ISSN:1226086X
DOI:10.1016/j.jiec.2017.06.001